13
Participants
Start Date
June 5, 2019
Primary Completion Date
September 3, 2024
Study Completion Date
June 16, 2027
Nicotinamide ribonucleoside
Two year intervention
Hilde Loge Nilsen, Lørenskog
Oslo University Hospital, Oslo
The Bergesen Foundation
OTHER
South-Eastern Norway Regional Health Authority
OTHER
Sykehuset Innlandet HF
OTHER
Oslo University Hospital
OTHER
St. Olavs Hospital
OTHER
Haukeland University Hospital
OTHER
University Hospital of North Norway
OTHER
University of Bergen
OTHER
University Hospital, Akershus
OTHER